About this trial

Investigating the effect of oxytocin on pancreatic endocrine functions by determining insulin and glucagon secretion within physiological ranges of plasma glucose.

Eligibility criteria

Qualifiers

BMI 19-25 kg/m2

Disqualifiers

Diabetes

Heart-, liver or kidney disease

More than 14 units of alcohol weekly, or drug abuse

Smoking or any kind of nicotine products

Trial design

Treatments tested in this trial

  • Oxytocin
  • Placebo

Treatment groups

20 Participants
are divided into 3 treatment groups

Locations

1
Center for Clinical Metabolic Research, Gentofte Hospital2900, HellerupCapital Region, Denmark

Sponsors and collaborators

University Hospital, Gentofte, Copenhagen

Lead sponsor